Here are some links to the data:
Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19: [(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473796/)]
FDA Requests Removal: enter text
Here are some links to the data:
Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19: [(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473796/)]
FDA Requests Removal: enter text
interesting finding but wouldn't you want to measure risk benefit of famotidine vs Ivermectin and inhaled steroids?
the point is, if we can develop a protocol with the most benefit and the least risk that is also prophylactic (as Ivermectin has been shown to be, as well as HCQ) it isn't necessary increase our dependency on drugs which should be discontinued:
https://www.innovativehealthclinic.com/functional-medicine-weston/dangers-of-acid-reflux-medications/
the solution to reduce stomach acid is based on a wrong understanding of the problem.